Fecal Microbial Transplant Enema

BIOLOGICAL3 trials

Sponsors

VA Office of Research and Development, University Health Network, Toronto, Polyclinic GrandMed

Conditions

Alopecia AreataCirrhosisFecal Microbiota Transplantation (FMT)Hepatic EncephalopathyLymphoma Receiving CAR-T TherapyMicrobiomeT Cell Subsets

Phase 1

FMT in Cirrhosis and Hepatic Encephalopathy

CompletedNCT03796598

VA Office of Research and DevelopmentCirrhosis, Hepatic Encephalopathy

Start: 2019-07-29End: 2023-12-20Updated: 2025-05-25

Unknown Phase

Fecal Microbiota Transplantation in Patients Undergoing Chimeric Antigen Receptor T-cell Therapy and Allogeneic Stem Cell Transplant: A Pilot Study

RecruitingNCT07509450

University Health Network, TorontoLymphoma Receiving CAR-T Therapy

Start: 2026-06-02End: 2029-06-02Target: 20Updated: 2026-07-08

The Role of Gut and Skin Microbiota in Alopecia Areata

Not yet recruitingNCT07705217

Polyclinic GrandMedAlopecia Areata, Fecal Microbiota Transplantation (FMT), Microbiome +1

Start: 2026-10-01End: 2027-10-01Target: 30Updated: 2026-07-15

Related Papers

The multi-omic basis for hepatic encephalopathy recurrence: Analysis of the THEMATIC trial.

2025-10-18

The Current and Future State of Microbiome Therapeutics in Liver Disease

The American Journal of Gastroenterology2023-12-287 citations